Mitochondria as a promising target for developing novel agents for treating Alzheimer's disease.

导出原文传递

翻译打印收藏纠错

作者： Elena F,Shevtsova ^[1] ; Andrey V,Maltsev ^[1] ; Darya V,Vinogradova ^[1] ; Pavel N,Shevtsov ^[1] ; Sergey O,Bachurin ^[1]

作者单位： Department of Medicinal and Biological Chemistry, Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, Moscow Region, Russia. ^[1]

关键词 Alzheimer disease mitochondria mitochondrial biogenesis mitochondrial permeability transition multitarget drug neurogenesis synaptic plasticity

主题词阿尔茨海默病(Alzheimer Disease);淀粉样β肽类(Amyloid beta-Peptides);人类(Humans);线粒体(Mitochondria);神经保护药(Neuroprotective Agents)

DOI 10.1002/med.21715

PMID 32687230

发布时间 2021-10-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览11

Medicinal research reviews

2021年41卷2期

803-827页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Mitochondria as a promising target for developing novel agents for treating Alzheimer's disease.

Medicinal research reviews

相似文献

Medicinal research reviews

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Mitochondria as a promising target for developing novel agents for treating Alzheimer's disease.

Medicinal research reviews

相似文献

Medicinal research reviews

相关期刊

检索历史清除